Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
gb2064 (1 trial)
hzvsf-v13 (1 trial)
Pneumonia (Phase 2)
Primary Myelofibrosis (Phase 2)
Trials (2 total)
Trial APIs (2 total)